本页面由Tiger Trade Technology Pte. Ltd.提供服务

Oncolytics Biotech Inc

0.9235
-0.0238-2.51%
成交量:39.30万
成交额:36.43万
市值:9,973.80万
市盈率:-3.23
高:0.9500
开:0.9340
低:0.9123
收:0.9473
52周最高:1.51
52周最低:0.3258
股本:1.08亿
流通股本:1.06亿
量比:0.73
换手率:0.37%
股息:- -
股息率:- -
每股收益(TTM):-0.2855
每股收益(LYR):-0.2881
净资产收益率:-769.06%
总资产收益率:-111.21%
市净率:1196.63
市盈率(LYR):-3.20

数据加载中...

2026/03/20

重要事件披露

Form 8-K - Current report
2026/03/19

重要事件披露

Form 8-K - Current report
2026/03/02

重要事件披露

Form 8-K - Current report
2026/02/24

重要事件披露

Form 8-K - Current report
2026/02/04

重要事件披露

Form 8-K - Current report
2026/01/15

重要事件披露

Form 8-K - Current report
2026/01/15

重要事件披露

Form 8-K - Current report
2026/01/12

重要事件披露

Form 8-K - Current report
2026/01/09

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2025/08/28

SEC问询函

Form CORRESP - Correspondence
2025/03/07

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2024/06/04

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/03/12

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2023/03/03

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2022/03/03

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2021/03/05

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2021/03/05

财报披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2021/03/05

财报披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/04/02

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/24

非美公司披露报告

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]